Laetitia Nebot-Bral
Post-Doctoral fellowship in immuno-oncology at Cancer Research UK Manchester Institute- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Français Native or bilingual proficiency
-
Anglais Full professional proficiency
-
Espagnol Elementary proficiency
Topline Score
Bio
Credentials
-
Utilisation des animaux à des fins scientifiques / Expérimentation animale - Niveau Concepteur Rongeurs
CNRS - Centre national de la recherche scientifiqueOct, 2017- Nov, 2024 -
Certificat de Synthèse Pharmaceutique : CSP
Université Paris-SudFeb, 2015- Nov, 2024 -
Cambridge English Certificate (CEC)
Cambridge English Language Assessment -
Certificat Informatique et Internet (C2i) (certification nationale)
Sous Direction des Technologies de l'Information et de la Communication pour l'Éducation (SD-TICE) -
Formation aux gestes et soins d'urgences (AFGSU)
CESU 92- Garches
Experience
-
Cancer Research UK Manchester Institute
-
United Kingdom
-
Research Services
-
100 - 200 Employee
-
Post-Doctoral fellowship in immuno-oncology
-
Mar 2022 - Present
Post doctoral fellowship in Santiago Zelenay's Lab, Cancer Inflammation and Immunity. Post doctoral fellowship in Santiago Zelenay's Lab, Cancer Inflammation and Immunity.
-
-
-
Gustave Roussy
-
France
-
Hospitals and Health Care
-
700 & Above Employee
-
PhD at UMR9019 Genome integrity and Cancers and Laboratory of OncoImmunology
-
Oct 2017 - Feb 2022
At the crossroads of DNA REpAir and iMmune signaling: From molecULar mechanisms to Cancer Therapy - DREAMFUL Project At the crossroads of DNA REpAir and iMmune signaling: From molecULar mechanisms to Cancer Therapy - DREAMFUL Project
-
-
-
Gustave Roussy
-
France
-
Hospitals and Health Care
-
700 & Above Employee
-
Pre-clinical studies in oncology
-
Oct 2016 - Jul 2017
Genetic instability & Immunity, a triumphal duo to predict Immune Checkpoint Blockade response? Genetic instability & Immunity, a triumphal duo to predict Immune Checkpoint Blockade response?
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Molecular biology in oncology
-
Apr 2016 - Sep 2016
Gene trap strategy, an innovative way to identify novel biomarkers of resistance to targeted therapies. Gene trap strategy, an innovative way to identify novel biomarkers of resistance to targeted therapies.
-
-
-
Gustave Roussy
-
France
-
Hospitals and Health Care
-
700 & Above Employee
-
Pharmacy extern at Gustave Roussy
-
Oct 2015 - Apr 2016
• Quality control of stem cells - Cellular Therapy Laboratory • Clinical trial magment - Pharmaceutical Clincal Trail Department • Retrocession of drugs under Autorisation Temporaire d'Utilisation (ATU). • Quality control of stem cells - Cellular Therapy Laboratory • Clinical trial magment - Pharmaceutical Clincal Trail Department • Retrocession of drugs under Autorisation Temporaire d'Utilisation (ATU).
-
-
-
Bioprojet
-
France
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Pre-clinical studies in neuropharmacology
-
May 2015 - Aug 2015
Identification of innovative drug candidates in neuropharmacology. Identification of innovative drug candidates in neuropharmacology.
-
-
-
Celgene
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Marketing oncology trainee
-
Jun 2014 - Sep 2014
Management of the Celgene Stand at congrès de la Société Française du Cancer (congrès SFC). Management of the Celgene Stand at congrès de la Société Française du Cancer (congrès SFC).
-
-
-
Greater Paris University Hospitals - AP-HP
-
France
-
Hospitals and Health Care
-
700 & Above Employee
-
Hospital internship in immuno-chemistry
-
Jul 2013 - Jul 2013
-
-
-
Pharmacie Autissier
-
Région de Paris, France
-
Part-time job in a retail pharmacy
-
Jan 2013 - Feb 2013
• Galenic: preparation of capsules, creams, lotions for therapeutic and cosmetic purposes. • Drug delivery • Galenic: preparation of capsules, creams, lotions for therapeutic and cosmetic purposes. • Drug delivery
-
-
Education
-
Université Paris-Saclay
Master 2 (M2), Pharmacologie pré-clinique, Pharmacologie clinique et Pharmacocinétique -
Université Paris-Sud (Paris XI)
Doctor of Pharmacy (Pharm.D.), Pharmaceutical industry, Mention BIEN en 3ème, 4ème et 5ème année de pharmacie et AB en 2ème année. -
Université Pierre et Marie Curie (Paris VI)
PACES (Première Année Commune aux Etudes de Santé)